A filing was made by Xenetic Biosciences raising the number of shares for its equity offering from the 1,555,555 in its preliminary prospectus to 1,649,113 common shares.
Xenetic Bio submits updated prospectus for upcoming equity offering
Sign up for BIO SmartBrief
Biotechnology industry news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.